AMARIN PHARMA
Amarin Pharma is a pharmaceutical manufacturing. They creates a new paradigm in cardiovascular disease management and is positioned to address cardiovascular risk for millions of patients globally. The product development program leverages its extensive experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids.
AMARIN PHARMA
Industry:
Biotechnology Health Care Manufacturing Medical Pharmaceutical Therapeutics
Founded:
1991-01-01
Address:
Bridgewater, New Jersey, United States
Country:
United States
Website Url:
http://www.amarinpharma.com
Total Employee:
501+
Status:
Active
Contact:
+1 855 827 2372
Email Addresses:
[email protected]
Similar Organizations
Abler
Abler is an equine pharmaceutical company that manufactures health care products to treat horse health conditions.
Acceleron Pharma
Acceleron is a biopharmaceutical company engaged in developing, manufacturing and commercializing novel biotherapeutics.
Amplexd Therapeutics
Amplexd Therapeutics develops topical treatments for HPV-induced cervical dysplasia, aiming to improve patient outcomes.
Asofarma
Asofarma is a pharmaceutical company that specializes in the development, production, and marketing of products for human use.
BCN Biosciences
BCN Biosciences is a pharmaceutical company that develops drugs related to cancer.
GelPharma
GelPharma is a pharmaceutical company that specializes in developing and manufacturing injectables, tablets, and soft gelatin capsules.
NCM - USA
NCM-USA provides a radiopharmaceutical manufacturing facility as well as a commercial radio pharmacy.
Pharmanetics
Pharmanetics is a theranostic management company specializing in managing the delivery of therapeutics affecting coagulation.
Postsurgical Therapeuticsthera
Postsurgical Therapeutics Inc. is a biotech firm developing a unique drug delivery system using polylactic glycolic acid.
Sumitomo Pharma America Holdings
Sumitomo Pharma America Holdings supports and enables the discovery, development, and commercialization of treatments to help patients.
Official Site Inspections
http://www.amarinpharma.com
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 15.197.225.128
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Amarin Pharma"
Company Profile | Amarin Global
Amarin is a global pharmaceutical company, focused on addressing cardiovascular health. We apply science, passion, and our global resources to support our BOLD vision to stop โฆSee details»
Leaders in Cardiometabolic Care | About Us | Amarin โฆ
Amarin is a global pharmaceutical company that has developed and is pursuing additional treatments to help address cardiovascular disease. Amarin is relentless in its pursuit of scientific breakthroughs that can lead to revolutionary โฆSee details»
Amarin Corporation - Wikipedia
Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa (AMR-101), a prescription grade omega-3 fatty acid. See details»
Amarin Corporation - LinkedIn
Amarin is an innovative pharmaceutical company leading a new paradigm in cardiovascular disease management. We are committed to increasing the scientific understanding of the โฆSee details»
Amarin Pharma, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Amarin Pharma, Inc. of Bridgewater, NJ. Get the latest business insights from Dun & Bradstreet.See details»
Amarin Corp
Amarin Corporation is a rapidly growing innovative pharmaceutical company, focused on developing and pursuing additional therapeutics to cost-effectively address cardiovascular โฆSee details»
Amarin Pharma - Crunchbase Company Profile
Amarin Pharma is a pharmaceutical manufacturing. They creates a new paradigm in cardiovascular disease management and is positioned to address cardiovascular risk for millions of patients globally. The product development โฆSee details»
Amarin Company Profile - Office Locations, Competitors, Revenue โฆ
Amarin has 5 employees across 3 locations and $306.91 m in annual revenue in FY 2023. See insights on Amarin including office locations, competitors, revenue, financials, executives, โฆSee details»
Company Location Information | Where We Are
Amarin is a global pharmaceutical company that has developed and is pursuing additional treatments to help address cardiovascular disease. Amarin is relentless in its pursuit of scientific breakthroughs that can lead to revolutionary solutions โฆSee details»
Amarin Corp
Amarin is a global pharmaceutical company, focused on addressing cardiovascular health. We apply science, passion, and our global resources to support our BOLD vision to stop โฆSee details»
Amarin - Crunchbase Company Profile & Funding
Amarin Corporation is a clinical-stage biopharmaceutical company focused on improving the treatment of cardiovascular disease. Amarinâโฌโขs lead candidate, AMR101, is currently being โฆSee details»
Amarin axes 120 of its 385 employees, hires new CEO Patrick Holt
Jul 19, 2023 With its revenue continuing to plummetโfrom $85 million in the first quarter to $65 million in the secondโAmarin is Amarin axes 120 of its 385 employees, hires new CEO โฆSee details»
Amarin to slash jobs as generic rivals dull U.S. prospects of heart ...
Jun 6, 2022 Amarin Corp Plc said on Monday it would cut its workforce by 40%, as the drugmaker's fish-oil derived heart drug faces stiff competition from generic rivals in the United โฆSee details»
Amarin Pharma Inc | Reuters
Feb 22, 2023 Amarin Pharma convinced a U.S. appeals court on Tuesday to resurrect a patent infringement lawsuit over Hikma Pharmaceuticals' generic version of Amarin's cardiovascular โฆSee details»
Management and Board of Directors - Amarin Corp plc
At Amarin, our core values guide every conversation. Our organizational decisions anchor the actions of our employees. Our purpose is motivated by our vision to reduce the burden of โฆSee details»
In reorganization, Amarin slashes US workforce, replaces CFO
Jun 6, 2022 A month ago, Amarin reported $96 million in first quarter sales of Vascepa, a 33% plunge from the same period in 2021. During the quarter, Amarin began taking on a third โฆSee details»
Amarin Pharma, Inc. v. FDA - Harvard Law Review
May 10, 2016 However, with the development of a muscular First Amendment commercial speech doctrine in recent years, the FDA has found its regulatory regime increasingly โฆSee details»
Step Inside the World of Amarin | Working at Amarin - Amarin โฆ
At Amarin, we consider our people to be our biggest asset. Find out how we achieve our shared goals and objectives. Our Values. From integrity to making an impact, our highly skilled global โฆSee details»
Amarin Partner EddingPharm Receives Regulatory Approval for โฆ
Jun 1, 2023 Amarin Corporation plc-- VASCEPA Approved by the National Medical Products Administration (NMPA) as an Adjunct to Diet to Reduce Triglyceride Levels in Adult Patients โฆSee details»